Patent Assignment
Reel/Frame 064118/0401
Assignment of Assignor's Interest
Recorded: 2023-06-29
Pages: 7
Assignor
CLEAVE THERAPEUTICS, INC.
Executed: 2023-05-17
Assignee
EIKON THERAPEUTICS, INC.
3929 POINT EDEN WAY, HAYWARD, CALIFORNIA, 94545
Covered Property
(1)
Fused Pyrimidines and Substituted Quinazolines as Inhibitors of P97
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 28, 2013
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 031490/0187 →
Assignment of Assignor's Interest
Jan 22, 2015
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO; WUSTROW, DAVID
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 034789/0921 →
Change of Name
Jul 24, 2023
From: CLEAVE BIOSCIENCES, INC.
To: CLEAVE THERAPEUTICS, INC.
Reel/Frame 064357/0295 →